key: cord-0813287-rvig8sjl authors: de Mesquita Souza Saraiva, Mauro; Lim, Kelvin; do Monte, Daniel Farias Marinho; Givisiez, Patrícia Emília Naves; Alves, Lucas Bocchini Rodrigues; de Freitas Neto, Oliveiro Caetano; Kariuki, Samuel; Júnior, Angelo Berchieri; de Oliveira, Celso José Bruno; Gebreyes, Wondwossen Abebe title: Antimicrobial resistance in the globalized food chain: a One Health perspective applied to the poultry industry date: 2021-11-13 journal: Braz J Microbiol DOI: 10.1007/s42770-021-00635-8 sha: 61301e61b5c750e319a487b1eb282a60155a06b8 doc_id: 813287 cord_uid: rvig8sjl Antimicrobial resistance (AMR) remains a major global public health crisis. The food animal industry will face escalating challenges to increase productivity while minimizing AMR, since the global demand for animal protein has been continuously increasing and food animals play a key role in the global food supply, particularly broiler chickens. As chicken products are sources of low-cost, high-quality protein, poultry production is an important economic driver for livelihood and survival in developed and developing regions. The globalization of the food supply, markedly in the poultry industry, is aligned to the globalization of the whole modern society, with an unprecedented exchange of goods and services, and transit of human populations among regions and countries. Considering the increasing threat posed by AMR, human civilization is faced with a complex, multifaceted problem compromising its future. Actions to mitigate antimicrobial resistance are needed in all sectors of the society at the human, animal, and environmental levels. This review discusses the problems associated with antimicrobial resistance in the globalized food chain, using the poultry sector as a model. We cover critical aspects of the emergence and dissemination of antimicrobial resistance in the poultry industry and their implications to public health in a global perspective. Finally, we provide current insights using the multidisciplinary One Health approach to mitigate AMR at the human-animal-environment interface. in the coming decade, and it is projected to account for half of all additional meat produced in that time period [3] . Poultry meat output was forecasted to expand and reach 137 million tonnes in 2020, a 2.6% rise compared to 2019, despite the dampened food services sales during the COVID-19 pandemic, intentional production curbs, and avian influenza outbreaks [4] . The USA, Brazil, the European Union, and China continue to be the leading producers of poultry meat globally [3] . Out of the total meat trade globally (37.6 million tonnes), 14.1 million tonnes (37.5%) relate to poultry meat exported by leading producing countries, making chicken the most exported type of meat. This highlights the great economic importance of the poultry industry as a global commodity, leveraging worldwide economic activities in the industrial, commercial, and service sectors. The relative affordability is an important driver for the increasing consumer willingness to replace beef and pork by poultry meat. Advantageous economies of scale and cost-efficiencies lead to cascading effects through poultry value chains from production to foreign trade [3] . Therefore, the industrial poultry production has a tradition to be in the vanguard in terms of technological advances in the areas of nutrition, breeding, management, and health. Moreover, the increasing demand for poultry meat is related to the growing demand for meat protein globally as the human population is expected to reach 9.7 billion in 2050 and 10.9 billion in 2100 [5] . Human population in less developed countries will at least double by 2050, whereas much lower growth rates will occur in developed areas [5] . For example, there is a dramatic increase (725 %) in the projected demand for poultry meat in South Asia by 2030, especially in countries such as India, where poultry meat consumption is estimated to grow from 1.05 to 9.92 million tonnes annually over the next three decades [6] . Given the increasing demand for poultry meat in highly populated urban areas, the poultry industry will move towards more intensified trade activities over the next decades. Technological development in the poultry industry will consolidate as a key driver for the success of the business and for reaching the society needs. These technologies must also improve the capacity of the industry to proper handle the increasing amount of animal waste, such as poultry litter, as it can be a vehicle for the spread of antibiotics, biocides, metabolites, pathogens, and antimicrobial resistance genes (ARG) in the environment [7] . The contamination of soil and water sources, such as rivers and ground-and coastal water, can have a profound and direct impact on the environmental resistome, especially in countries under poor sanitation conditions [7, 8] . In this scope, the technological development of the poultry industry should be embedded in Environmental, Social, and Governance (ESG) integrated initiatives for increasing performance and sustainability. Antimicrobial resistance is a natural, ancient, and common phenomenon in bacteria inhabiting any biological system [9] . However, some factors can favor the emergence and spread of antimicrobial resistance among bacteria. Anthropogenic factors seem to play an important role in this aspect, such as the overuse and misuse of antimicrobial agents, which generates selection pressure favoring the multiplication of antimicrobial-resistant organisms [10] . Antimicrobial agents can eliminate or inhibit the growth of susceptible bacteria, allowing resistant strains to colonize and multiply in a given environment. Several experimental, epidemiological, and ecological studies have confirmed this hypothesis [11] . Therefore, antimicrobialresistant pathogens have the potential to cause hard-totreat diseases, increased mortality rates, and economic burden. Infections caused by antimicrobial-resistant pathogens are considered major global public health crisis by the World Health Organization as the discovery of effective antimicrobial drugs does not keep pace with the increasing antimicrobial resistance rates in bacteria. The World Bank estimated that the loss of the annual global gross domestic product (GDP) by 2050 would fall 1.1% in the best case scenario of low AMR impact to 3.8% in the worst case scenario, which translates to an annual shortfall of $3.4 trillion by 2030 [12] . The O'Neill report on Review on Antimicrobial Resistance estimated the burden to be 10 million lives per year and cumulative 100 trillion USD of economic output by 2050 [13] . An estimation of global infections caused by drug-resistant WHO priority pathogens placed third-generation cephalosporinresistant Escherichia coli and Klebsiella pneumoniae to be responsible for approximately 4.6 to 6.4 million bloodstream infections in 2014 and carbapenem-resistant ones for approximately 0.4 to 0.5 million bloodstream infections [14] . In quantitative terms, the amount of antimicrobial drugs used in livestock globally was estimated in 63,151 tonnes in 2010, and it is expected to increase 67% by 2030, reaching approximately 105,500 tonnes [15] following the rising demand for livestock products by the human population in middle-income countries. The amount of antimicrobials used in livestock is estimated to nearly double in countries such as the BRICS countries (Brazil, Russia, India, China, and South Africa) . In spite of all efforts and competence of researchers working in this field, accurate numbers on the amount of antimicrobials used in food animals are extremely difficult to be reached because of lack of information and complexity of available data. There are important initiatives addressing data acquisition and availability, especially those led by the World Organization for Animal Health (OIE) database that serves as a global reference to national systems for monitoring the use of antimicrobials in animals. Nevertheless, these initiatives are at an early stage of development and face innumerous challenges related to the inaccessibly of data or calculation errors from many countries that are unable to provide reasonable accurate information [16] . Therefore, current calculations in terms of the amount of antimicrobials used in animals seem to be underestimated. According to the 2016 OIE report [16] , data collected from 93 countries globally indicated that Americas, Asia, and East Oceania used 87.13% from 97,784 tonnes of antimicrobial agents intended for animal use that year, even though only 18 countries were able to distinguish which drugs were used in terrestrial food animals. Tetracyclines (33.8%) and penicillins (20.4%) were identified as the most frequently used drugs in these animals. According to this same report, increased estimates of antimicrobial use were observed after adjustments by animal biomass, as shown in Table 1 [16] . Antimicrobial drugs have played an important role in intensive animal production systems, and a wide variety of antimicrobials can be used in poultry production [17, 18] . Antimicrobial therapy of diseased animals is not only the most promising alternative to overcome the economic burden caused by bacterial infectious diseases in livestock, but also represents a welfare principle that must be used to avoid suffering of any food animal. Therefore, the success of poultry farming and other animal production systems will continue to depend on the existence of effective antimicrobials. Besides therapy, antimicrobial drugs have been also used in poultry production for other purposes, such as metaphylaxis, i.e., the prophylactic treatment of the entire flock including animals that show no clinical sign of the disease in order to prevent the spread of a given disease, or as growth promoters, which are antimicrobials added to animal feed at low dosages to enhance animal performance. Although the use of antimicrobial drugs represents a driver for antimicrobial resistance in bacterial populations of every microenvironment using increased selective pressure, this phenomenon is significantly increased when antimicrobials are misused. Therefore, how antimicrobials are used in the food animal industry in terms of antimicrobial classes, the doses, and the purpose could have a great impact on the emergence and dissemination of antimicrobial resistance. While specific approved antimicrobials in veterinary medicine have been used therapeutically following veterinary recommendations, misuse of antimicrobials in food animals has been reported, such as the indiscriminate use of unprescribed drugs added to animal feed [19] or even added to vaccines [20] aiming to prevent disease and to improve animal performance. Thus, the use of antimicrobials in food animals should be also assessed in a qualitative perspective, given the fact that the non-therapeutic administration of antimicrobial drugs to livestock at sub-inhibitory dosages are supposed to have a greater impact on the emergence and dissemination of antimicrobial resistance. The problem is critical when these drugs relate to antimicrobial classes that are considered critically important to human health [21] , which makes the non-therapeutic use of these drugs a global health concern. There are indications that antimicrobials in animal food production are directly related to the increase of antimicrobial resistance [22] [23] [24] [25] . Importantly, there is a lack of new active principles or candidate interventions capable of overcoming resistance mechanisms developed by bacteria. Therefore, the rational use of these drugs seems the most adequate alternative to guarantee the effectiveness of already existing antimicrobials for treatment of diseases in animals and humans. As also occurring in other sectors, certain animal production practices might contribute to the spread of antimicrobial-resistant bacteria. These practices include overprescription of broad-spectrum antimicrobials to animals [26] , feeding of certain antibiotics at low doses for growth promotion purposes [27, 28] , and the use of non-approved or off-label use of drugs [29] . However, this drug overuse might be deposited as antibiotic residues in foodstuffs such as meat, eggs, and milk, to name a few [30] [31] [32] [33] . Several side effects have been related to antibiotic residues in foodstuffs, such as toxicity (bone Table 1 Amounts of antimicrobial drugs used in food animals by animal biomass before and after adjustments, by country estimates of data coverage. marrow and hepatotoxicity), nephropathy, immunopathological effects (allergy), mutagenicity, and, especially, transfer of antibiotic resistance between MDR and commensal bacteria that may contribute to the imbalance of gut microbiota posing hazards to human health [30] [31] [32] [33] . To address this concern effectively, some actions delivered by all sectors are needed to avoid the spread of these antimicrobial residues in foodstuffs. First, farmers must have the drug withdrawal period as a priority to safeguard human health. Second, the poultry industries must establish measurement strategies to detect antimicrobials in poultry products and related sources, including quantitative (liquid chromatography, capillary electrophoresis, enzyme linked immunosorbent assay), semi-quantitative (microbiology assay), and qualitative (x-ray diffraction) techniques [33] . Lastly, food authorities must be aware and monitor the previous steps made by the whole food chain sector. As in other sectors, the use of drugs in poultry production eliminates susceptible bacteria favoring the selection of resistant isolates. These persistent isolates become predominant and can transfer their resistance genes to both clonal descendants and also to other isolates from the same bacterial species or even from other species [34] . In this context, the problem of antimicrobial resistance in poultry production needs to be understood from two different perspectives: (i) the emergence and dissemination of antimicrobial-resistant zoonotic pathogens that represent a direct hazard in public health and (ii) the emergence and dissemination of commensal bacteria carrying ARGs in mobile genetic elements that can be further contributed as source of important resistance genes potentially transferred to pathogenic bacteria within a given host or in the environment [7, 8] . This explains the high complexity of antimicrobial resistance in the poultry industry, as illustrated in Fig. 1 . Another critical issue in the acquisition of resistance mechanisms is the identification of transmission routes of resistant bacteria along the food chain. Although it remains difficult to identify when the contamination begins, several insights can be denoted in One Health framework, including risk factors associated with the farm environment, food industry, and household settings as summarized in Fig. 1 . Among these factors, transmission via vectors, water, soil, plants, animal feed, poultry, and anthropological actions play a crucial role to the development and spread of antimicrobial resistance in a global scale [36] . [35] ). This figure was created using BioRe nder. com. A wide variety of antimicrobial-resistant bacteria of public health significance has been detected in broilers and laying hens. In this topic, we describe antimicrobial resistance levels among the most relevant zoonotic pathogens associated with chickens and poultry products: Salmonella spp. [37] [38] [39] , Campylobacter spp. [37, 40, 41] , Enterococcus spp. [42] [43] [44] , Escherichia coli [43, 45] , and Staphylococcus aureus [42, 46] . Salmonellosis affects hundreds of people around the world, causing high fever and diarrhea that can progress to death [47] . Because of its global importance, many countries have implemented surveillance programs for Salmonella in livestock, allowing the acquisition of important information about antimicrobial resistance. More than 2,650 serovars of Salmonella enterica have been already identified [48] , and several are found in foods such as chicken meat and eggs, considered key sources of infection and concern for public health [49] [50] [51] . In chickens, resistant Salmonella spp. not only can cause economic losses, but they can potentially cause occupational salmonellosis in farmers and keepers [52] [53] [54] . Salmonella diseases in birds can be divided into three distinct conditions: fowl typhoid, caused by Salmonella Gallinarum biovar Gallinarum (SG); pullorum disease, caused by Salmonella Gallinarum biovar Pullorum (SP); and avian paratyphoid, resulting from infection by any other serovar except those previously mentioned [55] . SG and SP only affect chickens and cause severe clinical signs and mortality, while SG affects birds of any age, and SP-associated infections occur in young birds. Chickens of light lineages are more resistant to fowl disease compared to semi-heavy and heavy lineages [56] . In contrast, paratyphoid Salmonella infections do not lead to clinical signs, but there are exceptions that can cause disease and mortality in chicks [55] . The epidemiology of salmonellosis is complex. The high density in the poultry houses along with the persistence of the microorganism in water, feed ingredients, litter, and fomites as well as in biological vectors on the farm environment facilitate its dissemination [57] . Transmission occurs through horizontal and vertical routes in the case of pullorum disease and avian paratyphoid [55, 58] , and only by horizontal route in fowl typhoid [59] . A previous study on semi-heavy laying hens showed that treatment with antimicrobials was able to reduce mortality caused by fowl typhoid only temporarily; death and compromised egg production were observed after treatment was suspended [59] . Thus, the efficacy of antimicrobials in controlling disease is limited and can promote the emergence of resistant Salmonella strains [55, 59] . In the case of paratyphoid Salmonella, multi-resistance is of concern as it promotes failures in the treatment of infection in humans who have ingested chicken meat or eggs contaminated by zoonotic serotypes such as S. Enteritidis, S. Typhimurium, S. Heidelberg, S. Hadar, S. Infantis, S. Mbandaka, S. Saintpaul, and S. Newport, among others [60] [61] [62] . A high and diverse level of antimicrobial resistance was identified in approximately 4,000 isolates from 14 different studies (Table 2 ). Nalidixic acid (95.2%), amoxicillin (91.6%), ampicillin (100%), erythromycin (100%), penicillin G (100%), sulfamethoxazole (100%), and tetracycline (93%) showed the highest resistances, while higher sensitivities were obtained for aminoglycosides (spectinomycin -96% and gentamicin -99.8%). The emergence and spread of antimicrobial-resistant, in particular multidrug-resistant Salmonella strains (MDR strains), is a major public health concern [63] . While Salmonella continues to be a major cause of foodborne disease in most countries, the reduced number of antimicrobials available for therapeutic purposes in humans and animals exacerbates the issue [64] . The proportion of Salmonella isolates resistant to ceftriaxone and ciprofloxacin in the USA has increased year on year [65] . MDR Salmonella recovered from chicken samples during veterinary inspection service in the USA has increased, remarkably for Salmonella Infantis [65] . Nontyphoidal MDR Salmonella is estimated to be responsible for 20,800 infections per year in the USA [66] . The most common antimicrobial resistance patterns of multidrug-resistant Salmonella strains related to important therapeutic antimicrobial classes are used in humans, including penicillins, tetracyclines, cephalosporins, and fluoroquinolones [28] . The frequency and extent of resistance in Salmonella varies according to the antimicrobial use and the ecological differences in its epidemiology [67] . Some multidrugresistant Salmonella strains with extensive resistance profiles pose greater threats to public health and have been associated with higher mortality and morbidity rates [41] . Multidrug resistance in Salmonella spp. to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (ACSSuT) has been associated with invasive disease in humans [64] . Another multidrug-resistant pattern with additional resistance to amoxicillin-clavulanic acid and ceftriaxone (ACSSuTAuCx) had been associated with severe disease in humans [68] , while the monophasic ST35 variant is associated to colistin resistance [69] . Campylobacter species can cause disease in animals and humans [70] and are a major cause of foodborne diseases worldwide. Both Campylobacter jejuni (C. jejuni) and C. coli can colonize the gut of broilers. Human infections, of particular concern when involving children [71] , are usually caused by consumption of contaminated poultry products, even though occupational transmission has been observed. Due to the high occurrence of Campylobacter spp. in the environment, including soil and water, and the high diversity of susceptible vector hosts [72, 73] ,, the epidemiology is Table 2 Summary of antimicrobial resistance results in Salmonella spp. isolated from poultry published in the last 5 years, within the five continents. AK amikacin, AMC amoxicillin/clavulanic acid, AMP ampicillin, AMX amoxicillin, AZI azithromycin, BAC bacitracin, C chloramphenicol, CAZ ceftazidime, CE cefradine, CEF ceftiofur, CFN cephalothin, CFZ cefazoline, CIP ciprofloxacin, CLX cefalexin, COL colistin, CPD cefpodoxime, CRO ceftriaxone, CTX cefotaxime, ENR enrofloxacin, ERY erythromycin, FEP cefepime, FFC florfenicol, FOX cefoxitin, GM gentamicin, KA kanamycin, NAL nalidixic acid, NEO neomycin, NIT nitrofurantoin, NOR norfloxacin, NV novobiocin, OT oxytetracycline, P penicillin, S streptomycin, SP spermidine, SPT spectinomycin, SUL sulfamethoxazole, SXT sulfamethoxazole/trimethoprim, T tetracycline, TGC tigecycline, TMP trimethoprim, TZP piperacillin/tazobactam, VAN vancomycin Reference (16, 9) very complex. Wild animals and pests, as well as humans and vehicles, can introduce Campylobacter spp. onto the farm [38] . Even though the real role of the feed as source of Campylobacter is unclear [41] , the bacteria can survive and multiply in foods under different storage temperatures [74] . High morbidity can be observed in domestic birds, and transmission occurs through both horizontal and vertical routes [41, 72, 75] . When infecting the bird, Campylobacter spp. effectively colonizes the intestine, mainly the mucosa of the cecal crypts. It can invade the intestinal epithelium and multiply rapidly in the intestinal mucus to avoid clearance [74] . In addition, it is able to persist under commensal conditions due to the weak immune response of the animal, making the bird a reservoir of human campylobacteriosis [41, 72] . Antimicrobial therapy, besides being ineffective in eliminating Campylobacter due to its high occurrence and commensal relationship in birds [41] , can promote the emergence of resistant strains. Therefore, biosecurity practices are the most appropriate way to reduce the infection at the flock level [72] . Other approaches such as the use of organic acids to reduce the pH of the gastrointestinal tract and competitive exclusion can reduce intestinal colonization by the microorganism [41, 75] . In nine recent studies, antimicrobial resistance profiles of more than 2,000 isolates of Campylobacter spp. were evaluated in broilers [76] [77] [78] [79] , laying hens [77] , chicken carcasses [77, [80] [81] [82] , and chicken meat or offal [81, 83, 84] . High frequencies of resistance to nalidixic acid (100-38.5%), ampicillin (100-8.8%), cephalexin (100-85.7%), ciprofloxacin Table 3 Summary of antimicrobial resistance results in Campylobacter spp. isolated from poultry published in the last 5 years, within the five continents. (100-7.1), erythromycin (100-0.9%), gentamicin (100-0%), and tetracycline (100-24.4%) were detected (Table 3) . Enterococcus species are part of the natural gut microbiota of both humans and animals and frequently contaminate the environment and foods, including chicken meat [85] . Although some strains have been used in probiotics, others have been reported as pathogenic strains for chickens [86] . In this case, there might be mortality without clinical signs during the acute phase, ranging from 1 to 3 weeks after infection [86] . In the case of clinical manifestation, septicemia is the most common observed condition. In general, transmission occurs via both horizontal and vertical routes. Among the pathogenic specimens for domestic birds, E. cecorum and E. faecalis can be highlighted [86] . E. cecorum has grown in importance from the past two decades after the epidemic of pathogenic strains in broilers, causing the so-called free thoracic vertebra (FTV) osteomyelitis [87] . The infection causes abscesses in the thoracic vertebrae that compress the spinal cord, leading the bird to remain supported under the tibiotarso-tarsometatarsal joint resulting from symmetrical paralysis of the posterior limbs [88, 89] . In addition, septicemia may occur with the appearance of fibrinoid pericarditis, hepatitis, and splenomegaly, which can progress to death [90] . Importantly, pathogenic strains are able to colonize the gut of birds in earlier development states compared with commensal strains, which has been attributed as an important driver for the occurrence of the disease [88] . On the other hand, E. faecalis has been associated with omphalitis and yolk sacculitis followed by sepsis and death of chicks in the first week of life, which may or may not be associated with Escherichia coli. Surviving animals may develop valve endocarditis and die in the chronic phase of the infection [86] . Enterococcus spp. can easily acquire resistance to antimicrobials and, therefore, play a central role in its dissemination [86] . Pathogenic E. cecorum strains are more resistant to antimicrobials than commensals [90] . Vancomycin-resistant Enterococcus spp. strains have been associated with economic losses in animal production and also with nosocomial diseases in humans [91] [92] [93] . Studies performed between 2014 and 2017 identified the presence of Enterococci species in broilers, laying hens [74, Table 4 Summary of antimicrobial resistance results in Enterococcus spp. isolated from poultry published in the last 5 years, within the five continents. , and chicken meat [98] [99] [100] , with frequencies ranging from 30.7 to 92%. High levels of resistance (Table 4) were found against drugs belonging to the class of aminoglycosides (streptomycin, 81.8-5%), tetracyclines (doxycycline, 67.3%; tetracycline, 82-7.5%), and quinolones (ciprofloxacin 97-2.5%; enrofloxacin, 69-17.9%). Vancomycin resistance was low (2-0.1%), with higher levels observed in isolates from chickens affected with vertebral osteomyelitis [101] . Escherichia coli (E. coli), a Gram-negative species belonging to the Enterobacteriaceae family, is of particular importance in the human-animal-environment triad. This species is often studied as a marker for antimicrobial resistance, mainly because of its wide distribution and its capacity to harbor several resistance genes in mobile genetic elements, therefore serving as a source of antimicrobial resistance genes to pathogenic strains [25, 102, 103] . In domestic birds, avian pathogenic E. coli (APEC) are causative agents of colibacillosis [104] [105] [106] . The number of serotypes causing the disease has been increasing [107] , although O1 and O78 remain as the most commonly detected serovars [104] . Colibacillosis is a complex local or systemic syndrome, in which the pathogen is easily transmitted orally, by inhalation or vertical route [108, 109] . E. coli containing several virulence genes are shown to lead to persistent and severe clinical diseases in birds [107] . In general, it is considered an opportunistic infection, occurring after the immune response becoming reduced due to stressful situations to the animal, immunosuppression, co-infections, and environmental problems (e.g., excess of ammonia), among others. However, more recently it has also been considered a primary pathogen that causes high economic loss [104, 109] . As for other bacteria species, its epidemiology is complex. Although pathogenic E. coli can be introduced onto the farm by different routes, the contact with wild birds, insects, and rodents [108] is of special importance. The incubation period is short, and birds can be asymptomatic and remain as such until death; in case of coli septicemia, birds become apathetic or moribund [108] . Clinical signs vary according to the syndrome, but the different conditions can result in localized anatomopathological changes, such as coliform omphalitis, coliform cellulitis, swollen head syndrome, and salpingoperitonitis in adults, or systemic such as colisepticemia, respiratory colisepticemia (aerosaculitis, chronic respiratory and complicated chronic respiratory diseases), osteoarthritis, synovitis, and coligranuloma (Hjarre's disease). They can lead to productive losses, ranging from rejects and carcass condemnation to death [108, 109] . Young birds are more susceptible to the pathogen, and high mortality rates are observed in embryos [108] . The success of vaccines has been challenged by the extensive number of serotypes. Therefore, the control of colibacillosis is very dependent of biosecurity measures [108] . The use of bacteriophages has been shown to help prevent colibacillosis with initial development in the respiratory tract and air sacs [110] , and in ovo administration of bacteriophages showed similar effect to treatment with enrofloxacin [111] . However, the use of bacteriophages is limited due to the type, bird age, administration route, dose used, and the fact that the elimination of the bacteria in the host can result in the release of endotoxins that lead to fever and toxic shock [112] . Control of colibacillosis with antimicrobials is a common practice, but there are problems resulting from the acquisition of resistance by microorganisms [112] , since resistant strains colonizing the gastrointestinal tract can be transmitted to humans and other animals [95, 113] . Table 5 shows the resistance levels of E. coli isolates from chickens and chicken meat [76, [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] . Some studies reported resistance to aminoglycosides, β-lactam groups (penicillins, cephalosporins), and fluoroquinolones in all tested isolates. Staphylococcus aureus (S. aureus) is an opportunistic agent that causes nosocomial diseases, which can lead from mild skin lesions to fatal endocarditis [127] . The greatest concern related to the worldwide spread of S. aureus [128] is the emergence of strains of methicillin-resistant S. aureus (MRSA), often found in humans and animals [129] . They are commonly isolated from chickens and can be transmitted to humans by direct contact or consumption of meat [130, 131] . Between 1998 and 2012, eight human outbreaks attributed to S. aureus of poultry origin were reported, resulting in 133 sick people and 19 hospitalizations in the USA [132] . Avian staphylococcosis can result in injuries that lead to economic losses due to decreased production and carcass condemnation. The epidemiology is complex since it is widespread in the environment and in the skin and mucosa of animals and humans [133] . MRSA strains have already been detected in rodents [134] , which can introduce multiresistant pathogens in poultry farms [133] . Table 6 summarizes the results of antimicrobial resistance in S. aureus obtained from studies between 2015 and 2018. The greatest resistances were found for amoxicillin (100%), amoxicillin-clavulanic acid (80-5%), ampicillin (100-5.9%), cefoxitin (100-10.5%), kanamycin (79.3-5, 2%), penicillin (100-2.1%), and tetracycline (91.2-10%). ST398 was the most detected strain among all isolates described in these studies that originated from chickens [123, [135] [136] [137] and chicken meat [138] [139] [140] [141] [142] . Bacteria can acquire resistance against antimicrobial drugs by either spontaneous mutation (in both pre-existing or newly acquired genes) or horizontal gene transfer [143] . Considering the possibility of commensal bacteria to carry and spread ARGs through horizontal gene transfer mechanisms, foodstuffs are potential sources of ARGs to human bacteria. Horizontal gene transfer refers to the transfer of ARGs [144] from resistant to susceptible strains, allowing bacteria to successfully adapt and colonize new environments [11] . Genes coding for antimicrobial resistance can be found in various mobile DNA elements, e.g., plasmids, transposons, genomic islands, and integrons [145] . Horizontal gene transfer can occur through bacterial transformation, transduction, or conjugation. Bacterial transformation is the process by which a recipient bacterium takes up and assimilates free DNA, which carries the resistance genes Table 5 Summary of antimicrobial resistance results in Escherichia coli isolated from poultry published in the last 5 years, within the five continents. AK amikacin, AMC amoxicillin/clavulanic acid, AMP ampicillin, AMX amoxicillin, AZI azithromycin, C chloramphenicol, CAZ ceftazidime, (100), AZI (2, 9) , C (42, 9) , CAZ (62, 9) , CIP (91, 4) , COL (2, 9) , CTX (65,7), GM (2, 9) , MEM (0), NAL (54, 3) , SUL (80), T (62, 9) , TGC (0), TMP (74, 3) from the environment [146] . Bacterial transduction involves the transfer of DNA from bacteriophages to bacteria [146] . Plasmid transfer is probably the most frequent mechanisms of horizontal transfer of resistance genes. It refers to the selftransfer of a conjugative plasmid or transposon to a recipient cell [146] . Conjugative plasmids are the most common vectors for the transmission of antimicrobial resistance genes [143] . Plasmids are autonomously replicating extra-chromosomal DNA molecules that range from <2 and >100 kb in size [146] . They can confer resistance to one or several classes of antimicrobials, including beta-lactams, aminoglycosides, tetracyclines, phenicols, sulfonamides, trimethoprim, macrolides, and quinolones [147] . The spread of antimicrobial resistance in Gram-negative bacteria has been largely attributed to DNA exchange via conjugation of plasmids carrying ARGs [148] . Multiresistance plasmids can be transferred into a susceptible bacterial host independently of whether there is selection pressure for one or all the resistance genes [146] . Thus, the persistence of a gene conferring resistance to a given antimicrobial could occur without the selection pressure on the gene itself. Following the ban of avoparcin, a glycopeptide antibiotic analogue of vancomycin, the prevalence of vancomycin-resistant E. faecium in broilers dropped from 72.7% in 1995 to 5.8% in 2000 [149] . However, the prevalence in pigs did not decrease until the use of tylosin was reduced. It was shown that tylosin provided the selective pressure for E. faecium to maintain the vancomycin-resistant vanA-erm(B) plasmid which also carried tylosin resistance genes [149] . This is also known as co-resistance, a mechanism of co-selection, when genes conferring a number of antimicrobial resistance phenotypes are located on the same genetic element such as a plasmid or integron [150] . Another mechanism of co-selection, known as cross-resistance, allows bacteria to survive the effects of more than one drug after acquisition of a given antimicrobial resistance gene or mutation [151] . The surveillance of commensal bacterial in foodstuff carrying antimicrobial resistance genes has been used in surveillance programs as an indicator of the level of antimicrobial resistance. Advances in high-throughput analytical methods can provide valuable information on quali-quantitative assessment of chicken products regarding the levels of ARGs. As the major risks for human-associated diseases caused by multidrug-resistant pathogens have been linked to the consumption of contaminated food, or direct contact with animals, a thorough investigation of the source of antimicrobial-resistant foodborne pathogens upstream in the production cycles is needed to effectively tackle the problem. For many pathogens, transmission pathways are often very complex and involve wildlife and the environment as reservoirs. In view of the amount of information available in the literature, this section will focus on the control of Salmonella organisms. A recent investigation of Salmonella recovered from captive wildlife host species and the environment in Ohio, USA, determined that indirect transmission of Salmonella could occur among animal hosts via environmental contamination [152] . The same study reported multidrug-penta-resistant Salmonella types (AmSTTeKmGm), suggesting that the role of wildlife and environment in the transmission of antimicrobial resistance to production animals and humans could be underestimated. Interventions are typically most cost-effective and practical for the control of multidrug-resistant foodborne pathogens when applied upstream in the food supply chain at the farm level, reducing their occurrence and spread through the food chain. Strategies to prevent human MDR-foodborne pathogens, such as Salmonella, have broadened from pre-harvest control at the farm level to post-harvest control of food products [153] . The problem associated with the occurrence of these pathogens in the poultry industry is multifactorial and requires solutions addressing micro-ecosystems and multiple variables. This can be summarized into four key control strategies, namely, vaccination, testing, flock management and sanitation, and gastrointestinal colonization control [153] . Immune responses triggered by vaccinations can reduce the duration and severity of Salmonella infections in chickens, as well as prevent reinfections. However, it cannot completely prevent infections. Poor sanitation, inadequate vaccine management and environmental stress on the chickens can adversely impact vaccine performance. Vaccines also have limited efficacy against field strains or emerging Salmonella serotypes which are antigenically different from vaccine strains. In response to the dramatic increase in human salmonellosis due to egg-transmitted S. Enteritidis, several testing and quality assurance programs for commercial laying flocks have been proposed by government agencies and the private sector. In the USA, a combination of environmental sampling, serologic testing, and bacteriological culturing of birds has been employed. The National Poultry Improvement Plan (NPIP) was designed to be a cooperative industry, state, and federal testing and monitoring program to eliminate some poultry diseases including S. Pullorum and S. Enteritidis. However, testing retains a degree of uncertainty and has limited value in predicting or responding to emerging reservoirs of Salmonella infection or serotypes. Effective biosecurity and hygiene practices as part of flock management and sanitation is crucial, since all other measures would fail if these were not executed appropriately. Effective biosecurity and hygiene practices could be further elaborated upon to include disinfection practices, pest controls, animal, person and vehicle movements, feed, water, and sources of poultry. There are various products promoted as feed additives or treatments that not only improve animal health but can also protect birds from Salmonella infections. Some acidic compounds or organic acids have been shown to directly reduce colonization and shedding of Salmonella [154] . Prebiotics are non-digestible feed ingredients that stimulate the growth of one or a limited number of resident beneficial bacterial species in chickens [155] . Competitive exclusion products are gastrointestinal contents of adult poultry given to chicks to establish an adult microflora that is resistant to Salmonella colonization [156] . Probiotics are living microbial feed ingredients that have anti-inflammatory effects and the potential to modify the microbiological ecosystem within the poultry gut to control Salmonella [157] . Bacteriophages, live viruses that attack bacteria, have shown promise in reducing colonization in experimental trials [158] , but field trial studies are limited [154] . Phytobiotics may modulate the chicken microbiome similar to antimicrobials [159] , prevent the biofilmproduction [160] , and prevent gastrointestinal diseases in broilers [161] , without causing neither collateral effects to birds [162] nor selection pressure to antimicrobial resistance in bacteria [163] . Finally, potential feed additives, such as flavophospholipol, could have the beneficial effect of reducing both Salmonella shedding and the number of animals carrying Salmonella at slaughter [164] . Programs addressing the surveillance of antimicrobial resistance in the food chain have been implemented in some countries and are currently under implementation in many others. They are normally focused on the primary production level (pre-harvest) but can also include the surveillance in animal-derived products (post-harvest). Although targeting mainly foodborne zoonotic bacteria, these programs can also include classic zoonotic agents and animal pathogens as well. In Europe, the basis for the monitoring of antimicrobial resistance in the food chain In USA, the National Antimicrobial Resistance Monitoring System (NARMS) is the surveillance system tracking antimicrobial resistance in foodborne pathogens from different sources, including poultry and chicken products. NARMS was established in 1996 after an expert panel convened by the US Food and Drug Administration (FDA) recommended, in 1994, establishing a national surveillance system to monitor resistance among selected enteric bacteria of animals that can cause disease in humans [169] [170] [171] . NARMS is a collaborative effort of three federal agencies, CDC, FDA, and the United States Department of Agriculture (USDA), as well as state and local health departments in all 50 states. It was designed to help assess the consequences to human health arising from the use of antimicrobial drugs in food animal production with a view towards mitigation [172] . The main goals of NARMS are to monitor trends in antimicrobial resistance among enteric bacteria from humans, retail meats, and animals, in addition to disseminate timely information on antimicrobial resistance in pathogenic and commensal organisms to stakeholders in the USA and abroad to promote interventions that reduce resistance among foodborne bacteria. Moreover, other goals include encouraging research to better understand the emergence, persistence, and spread of antimicrobial resistance and to provide data that assist FDA in making decisions related to the approval of safe and effective antimicrobial drugs for animals [173] . Since 2016, under the coordination of the Ministry of Health, Brazil has been implementing its National Action Plan (PAN-BR). The Plan is also in line with the Global Action Plan, defined by the tripartite alliance among the World Health Organization (WHO), the OIE, and the Food and Agriculture Organization (FAO), on the "One Health" concept and involves coordination with the Brazilian Ministry of Health, the Health Regulatory Agency (ANVISA), the Ministry of Agriculture, Livestock, and Food Supply (MAPA), the Ministry of Science, Technology, Innovations and Communications (MCTIC), the Ministry of Cities, the Ministry of Education, and the Ministry of the Environment [174] . In May 2018, MAPA published the National Action Plan on Antimicrobial Resistance in Agriculture (PAN-BR Agro) which has been integrated into the PAN-BR. The PAN-BR Agro presents eight main objectives, 15 strategic interventions, and 21 activities to be implemented up to 2022 [175] . The plan targets health education, epidemiological studies, surveillance and monitoring of antimicrobial use, strengthening infection prevention and implementation of control measures, and promotion of antimicrobial rational use in animals. It can be expected that the data gaps on antimicrobial use will be solved by these activities. Moreover, the regulation of antimicrobial use, such as the need of veterinary prescriptions, the research of alternatives for antimicrobials used as growth promoters, and education programs will contribute to the prudent use of antimicrobials. Some of the activities include several workshops, the implementation of surveillance system to monitor AMR in bacteria recovered in official pathogen monitoring programs, and development of the monitoring program on antimicrobial use in animals, among others [176] . The WHO has reiterated guiding principles to manage antimicrobial resistance in food animals through measures such as enhanced surveillance and better animal husbandry. Better animal husbandry practices include phasing out the use of medically important antibiotics for the treatment of humans as performance enhancers in animal production. Following joint workshops among the WHO, OIE, and FAO on non-human antimicrobial usage and antimicrobial resistance, OIE has developed standards and guidelines to address antimicrobial resistance issues including the responsible and prudent use of antimicrobials and the development of surveillance and monitoring programs for antimicrobial resistance. In 2005, the Codex Alimentarius Commission issued a code of practice to countries in order to mitigate antimicrobial resistance. In response to the abuse and misuse of antimicrobials in the USA, the Food and Drug Administration (FDA) developed strategies outlined under the guidance document #209 on "The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals." Medically important antimicrobial drugs refer to antimicrobial drugs that are important for human therapeutic use. The two guiding principles are that "the use of medically important antimicrobials in food-producing animals should be limited to those uses that are considered necessary for assuring animal health" and "the use of medically important antimicrobial drugs in food-producing animals should be limited to those uses that include veterinary oversight or consultation." While legislations and initiatives to limit antimicrobials except for therapy in food-producing animals could be put in place, it seems likely that such changes alone would not solve the problem of antimicrobial resistance. The American Veterinary Medical Association (AVMA) highlighted that the contribution of antimicrobial use in animal production to the global dissemination of antimicrobial resistance is probably limited [177] . Denmark banned the use of several antimicrobial growth promoters in food animals from 1994 to 1999, and a voluntary ban on the use of cephalosporins in pig production was implemented in 2010. According to the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP) report for 2013, the prevalence of antimicrobial-resistant bacteria remained constant or on the rise [178] . The report stated that S. Typhimurium isolates among Danish pigs exhibited high levels (range 33-47%) of resistance to ampicillin, streptomycin, sulfonamide, and tetracycline. This co-resistance to four antimicrobial classes refers to the ASSuT profile and could be seen alone or together with resistance to other antimicrobial classes. Resistance to tetracycline increased from 2012 to 2013, while resistances to other antimicrobial agents were similar to levels reported in 2012 [178, 179] . The level of multidrug-resistance among E. coli isolates in Danish broiler chickens and broiler meat has more than doubled within the past 5 years, reaching 16-18% in 2013 [178] . It was presumed to be driven by an increased therapeutic use of tetracycline in poultry production as subtherapeutic use was banned. There were no significant changes in levels of resistance from of Salmonella infections in humans between 2009 and 2013. In the 10-year period from 2004 to 2013, resistance in E. coli human blood isolates to 2nd generation cephalosporins, ciprofloxacin, and aminoglycoside increased steadily [178] . While it is crucial to ban important antimicrobials in animal production, the Danish experience showed that further approaches are needed not only to reduce foodborne pathogens in animal-derived foods but also the transmission of antimicrobial resistance. There will be or already are stricter rules or bans on antibiotic growth promoters globally, although it is recognized that there cannot be a total ban on antibiotic use in food animals, at the expense of dramatic adverse health consequences on animals and limitation of tools at the disposal of veterinarians [180] . A solution suggested in stewardship bootcamps for and against the use of antimicrobials in food animals [181] is the use of alternative feed additives that could reduce foodborne pathogen carriage and shedding, promote growth, and reduce the incidence of antimicrobial-resistant bacteria in the gut of food animals [182] . Although there is a consensus that actions must be taken to reduce the emergence and spread of antimicrobial resistance in livestock, those actions must consider key premises: 1) Antimicrobial resistance is an inevitable biological phenomenon in bacteria that is accelerated by antimicrobial use selective pressure. The actions should address the critical aspects of antimicrobial resistance to human, animals, and the associated ecosystem. The alternatives to control antimicrobial resistance need to be supported by scientific-based knowledge. 2) The animal industry plays a key role in the global food supply. Fighting antimicrobial resistance need to consider economically feasible alternatives that warrant the success of the industries and the sustainable development of the regions where they are located. 3) All sectors of the society, including the decision-makers in the companies, must understand that antimicrobial resistance is a critical topic for the present and future of the human civilization. If this is somehow difficult to be grabbed, the companies' lack of commitment on the reduction of antimicrobial-resistant could jeopardize the success of their business. 4) Governments must understand that fighting antimicrobial resistance requires coordinated efforts with the private sector to promote disruptive shifts. That requires an adequate environment for research, development actions, and cost compensation. 5) There is no villain nor magic bullet for the control of antimicrobial resistance. Its mitigation depends on the coordinate multidisciplinary efforts and strengthens capacity building and education. The One Health approach must be embraced as a disruptive platform to tackle antimicrobial resistance and other complex problems. As explained in the previous sections of this manuscript, antimicrobial resistance is very complex multi-branched problem that require actions at the human, animal, and environmental levels. Awareness (or lack thereof) is growing on the overlap of individual, regional, and global public health, as well as the health of humans, animals, and the environment [183] . The "One Health" concept involves an interdisciplinary, cooperative approach and is captured in this statement: "collaborative efforts of multiple disciplines, working locally, nationally and globally, to reach optimal health for people, animals and the environment." [184] The concept of "One Health" or "One Medicine" is not new. It was first mentioned by Dr. Calvin Schwabe who recognized that collaboration between human and veterinary professionals is needed to control zoonotic diseases [185] . Following the 2015 World Health Assembly, a global action plan on AMR was adopted [186] . The plan underscores the strong collaboration between the WHO, FAO, and OIE to work with United Nations to combat AMR at the political level. The objective was to have multi-sectorial national action plans by 2017. AMR is also only one of three priority areas that the tripartite organizations have agreed to work on, in addition to rabies and avian influenza. The WHO recommended an overall reduction in the use of medically important antimicrobials in food-producing animals, as well as a complete restriction in the use of such antimicrobials for growth promotion and disease prevention [187] . The FAO action plan of 2016-2020 focuses on improving awareness, developing surveillance and monitoring capacity, strengthening governance, and promotion of good practices [188] . The plan has since been updated to 2021-2025 to cover research and allocation of resources sustainably. The OIE also announced its strategy on AMR in 2016, covering similar areas, with an addition of encouraging the implementation of international standards. The One Health Global Leaders Group on antimicrobial resistance (Global Leaders Group) has recently been established, which was a recommendation by the Interagency Coordination Group (AMR) on Antimicrobial Resistance. The United Nations Environment Programme (UNEP) is also slated to join the tripartite to combat AMR. This is a positive move to ensure that the One Health approach and political commitment are maintained. Interestingly, the "One Health concept" has begun to be incorporated in the animal production systems. For instance, a certification program for animal-derived foodstuff produced according to the One Health principles (One Health Certification) has been recently launched. Additionally, other initiatives such as the One Health Poultry Hub, led by the U.K. Royal Veterinary College (RVC), will concentrate efforts in Bangladesh, Sri Lanka, and Vietnam and will look at why intensification of poultry production increases the risk of infectious disease and identify high-risk behaviors, processes, and environments. It will also test and evaluate novel interventions for disease control. With a GBP19.1 million (US$2.5 million) funding, the major goals of this hub are to assist in the development of policies for the environmental, economic, and social sustainability of poultry production systems and reduce threats to human and animal health and welfare. Bacterial food poisoning, avian influenza, and antimicrobial resistance are among the key areas for collaborators in the hub. While such initiatives are welcome, poultry companies need to not only apply the principles of One Health, but they need to communicate this compliance with consumers, in order to build consumer trust. Given the inter-sectorial nature of AMR, the poultry industry also needs to join forces with representatives of other sectors, including wildlife and environmental agencies, as these serve as sentinel for AMR [189] . The antimicrobial resistance is probably the clearest example of an increasing multifaceted problem requiring solutions in One Health. The vision that embraced the antimicrobial resistance with a more heuristic vision, including actions at the different levels such as humans, animals, and the environment, is important, but will not solve or enable the civilization to efficiently tackle the problem. One Health initiatives on antimicrobial resistance must include actions addressing the key factors related to the emergence of AMR: political willingness and education on how we interact with the surrounding environment. While we recognize that much must be done in order to better understand the complexity of AMR, recent epidemiological studies agree that the solution is aligned with the principles of global health promotion, reduction of inequity, and investments on research and development to improve our capacity to understand the problems and propose effective control measures. Importantly, investments on research and development must require interdisciplinary approaches involving social scientists, economists, and natural science components. For example, many aspects of the misuse of antimicrobials in human and veterinary medicine, considered key drivers for the emergence of antimicrobial resistance, are related to social behavior. Lastly, political willingness is of crucial importance, as only coordinate actions among the many organizational levels could resonate. In poultry farming, a wide range of bacterial species can infect broiler and layer chickens. As in other sectors, the emergence and dissemination of antimicrobial resistance among those bacteria have been posing a serious threat to the whole society, including the industry itself, because: 1) Avian diseases caused by drug-resistant bacteria are more difficult to be treated, leading to aggravated economic losses. Furthermore, animal-derived products have the potential to carry commensal bacteria harboring important antimicrobial resistance genes. The levels of resistance genes or resistant commensal bacteria in foodstuff can be used as non-tariff barriers for exporting countries. 2) Some of these bacteria are zoonotic pathogens, increasing the risk for consumers or workers to also acquire hard-to-treat infections, representing a burden to public health. Antimicrobial resistance represents a long-term and very complex biological problem; therefore, coordinate and accurate actions are necessary in order to reduce its impact on the present and the future of the human civilization. Such measures need to be performed upon science-based knowledge in order to preserve the economic efficiency of the industry along with the promotion of public health. In this sense, Environmental, Social, and Governance (ESG) integrated initiatives in the poultry industry are encouraged to embrace One Health principals. Meat and dairy production. Our World Data FAO (2020) Meat market review, overview of global meat market developments in 2019 OECD/FAO (2020) Meat. In: OECD-FAO agricultural outlook FAO (2020) Food outlook -biannual report on global food markets Mapping suppying and demand for animal Antimicrobial resistance: a One Health perspective One Health -its importance in helping to better control antimicrobial resistance Antibiotic resistance is ancient Veterinary drug usage and antimicrobial resistance in bacteria of animal origin Resistance in bacteria of the food chain: epidemiology and control strategies Drug-resistant infections: a threat to our economic future Tackling drug-resistant infections globally: final report and recommendations Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study Global trends in antimicrobial use in food animals Organization for Animal Health (2020) Annual report on antimicrobial agents intended for use in animals -better understanding of the global situation The use of antimicrobial agents in broiler chickens Use of antimicrobial agents in livestock Reassessing flavophospholipol effects on broiler performance. Rev Bras Zootec Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut Critically important antimicrobials for human medicine: ranking of antimicrobial agents for risk management of antimicrobial resistance due to non-human use Impact of third-generation-cephalosporin administration in hatcheries on fecal Escherichia coli antimicrobial resistance in broilers and layers Antimicrobial resistance of zoonotic and commensal bacteria in Europe: the missing link between consumption and resistance in veterinary medicine Antimicrobial resistance of faecal Escherichia coli isolates from pig farms with different durations of in-feed antimicrobial use Antimicrobial usage and antimicrobial resistance in animal production in Southeast Asia: a review Antimicrobial agents are societal drugs: how should this influence prescribing? Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production Antimicrobial use in animal feed -time to stop Antibacterial resistance: current problems and possible solutions Antibiotic residues -a global health hazard Detection of antibiotic residues in poultry meat Importance of antibiotic residues in animal food Antibiotic residues in food animals: public health concern The epidemiology of antibiotic resistance Current insights on high priority antibiotic-resistant Salmonella enterica in food and foodstuffs: a review Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis Salmonella and Campylobacter: antimicrobial resistance and bacteriophage control in poultry Salmonella isolated from chicken carcasses from a slaughterhouse in the state of Mato Grosso, Brazil: antibiotic resistance profile, serotyping, and characterization by repetitive sequencebased PCR system Genomic comparison of non-typhoidal Salmonella enterica serovars Typhimurium, Enteritidis, Heidelberg, Hadar and Kentucky isolates from broiler chickens Global epidemiology of Campylobacter infection Campylobacter in poultry: ecology and potential interventions Human health risks associated with antimicrobial-resistant enterococci and Staphylococcus aureus on poultry meat Drug use and antimicrobial resistance among Escherichia coli and Enterococcus spp. isolates from chicken and turkey flocks slaughtered in Quebec First report on a randomized investigation of antimicrobial resistance in fecal indicator bacteria from livestock, poultry, and humans in Tanzania Oral administration of antimicrobials increase antimicrobial resistance in E. coli from chicken-a systematic review A novel methicillin-resistant Staphylococcus aureus t11469 and a poultry endemic strain t002 (ST5) are present in chicken in Ebonyi State Salmonella (nontyphoidal ) to the white-Kauffmann-Le minor scheme Characterization of extended-spectrum β-lactamase (ESBL) producing non-typhoidal Salmonella (NTS) from imported food products Salmonellosis: the role of poultry meat Antimicrobial residues and resistance against critically important antimicrobials in nontyphoidal Salmonella from meat sold at wet markets and supermarkets in Vietnam Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens An economic evaluation of PulseNet: a network for foodborne disease surveillance Salmonella infections. Dis Poult The genomic architecture of fowl typhoid resistance in commercial layers Experimental infection of one-day-old chicks with Salmonella Serotypes Previously isolated from poultry facilities, wild birds, and swine Epidemiology and economic importance of pullorum disease in poultry: a review Further investigations on the epidemiology of fowl typhoid in Brazil Prevalence and antimicrobial resistance of Salmonella serotypes isolated from poultry in Spain: comparison between 1993 and Epidemiological, molecular characterization and antibiotic resistance of Salmonella enterica serovars isolated from chicken farms in Egypt Fifteen years of successful spread of Salmonella enterica serovar Mbandaka clone ST413 in Poland and its public health consequences Antimicrobial resistance in nontyphoidal Salmonella Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations NARMS update: integrated report summary US Department of Health and Human Services, Centres for Disease Control and Prevention Antimicrobial Resistance in nontyphoidal Salmonellae Emergence of multidrug-resistant Salmonella enterica Serotype Newport Infections Resistant to Expanded-Spectrum Cephalosporins in the United States Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli Campylobacter spp. as a foodborne pathogen: a review Campylobacter infections in children exposed to infected backyard poultry in Egypt Poultry as a host for the zoonotic pathogen Campylobacter jejuni. Vector-Borne Zoonotic Dis Prevalence and types of Campylobacter on poultry farms and in their direct environment Colonization strategy of Campylobacter jejuni results in persistent infection of the chicken gut Control of Campylobacter in poultry industry from farm to poultry processing unit: a review The establishment of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS): a pilot project on poultry farms, slaughterhouses and retail market Multidrug resistant Campylobacter in faecal and carcasses of commercially produced poultry Antimicrobial-resistant Campylobacter in organically and conventionally raised layer chickens Prevalence, antimicrobial resistance and genetic diversity of Campylobacter coli and Campylobacter jejuni in Ecuadorian broilers at slaughter age Prevalence and antimicrobial resistance of Campylobacter isolated from carcasses of chickens slaughtered in Poland -a retrospective study Prevalence, antimicrobial resistance profiling and genetic diversity of Campylobacter jejuni and Campylobacter coli isolated from broilers at slaughter in China Prevalence and fluoroquinolones resistance of Campylobacter and Salmonella isolates from poultry carcasses in Rio de Janeiro Campylobacter in broiler chicken and broiler meat in Sri Lanka: influence of semi-automated vs. wet market processing on Campylobacter contamination of broiler neck skin samples Characterization of Campylobacter species in Spanish retail from different fresh chicken products and their antimicrobial resistance Antimicrobial resistance in Enterococcus spp. of animal origin Borst LB (2020) Streptococcus and Enterococcus. In: Swayne DE (ed) Diseases of poultry Enterococcus cecorum septicemia as a cause of bone and joint lesions resulting in lameness in broiler chickens Pathogenesis of enterococcal spondylitis caused by Enterococcus cecorum in broiler chickens Vaccination of breeder hens with a polyvalent killed vaccine for pathogenic Enterococcus cecorum does not protect offspring from enterococcal spondylitis A review of Enterococcus cecorum infection in poultry Nosocomial infections and their control strategies Phenotypic and genotypic characterization of Enterococcus cecorum strains associated with infections in poultry Characterization of pathogenic Enterococcus cecorum from different poultry groups: Broiler chickens, layers, turkeys, and waterfowl Antimicrobial susceptibility of indicator bacteria isolated from chickens in southeast Asian countries Antimicrobial susceptibility patterns of Enterococcus faecalis and enterococcus faecium isolated from poultry flocks in Germany Antimicrobial resistance and virulence profile of enterococci isolated from poultry and cattle sources in Nigeria Prevalence and antibiotic resistance of Enterococcus strains isolated from poultry Occurrence and antimicrobial resistance of enterococci isolated from organic and conventional retail chicken Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia) Prevalence and antimicrobial resistance of enterococci isolated from retail meats in the United States Genetic diversity and antimicrobial resistance profile of Enterococcus faecalis isolated from broilers with vertebral osteomyelitis in Southeast Brazil The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014 Antimicrobial resistance and integron gene cassette arrays in commensal Escherichia coli from human and animal sources in IRI Is the concept of avian pathogenic Escherichia coli as a single pathotype fundamentally flawed? Genetic diversity of Escherichia coli isolates of animal and environmental origins from an integrated poultry production chain ) mcr-1 identified in avian pathogenic Escherichia coli (APEC) Virulence gene content in Escherichia coli isolates from poultry flocks with clinical signs of colibacillosis in Brazil Colibacilosis Avian colibacillosis: still many black holes Bacteriophage therapy to combat bacterial infections in poultry Critical evaluation of bacteriophage to prevent and treat colibacillosis in poultry Characteristics of Escherichia coli isolated from broiler chickens with colibacillosis in commercial farms from a common hatchery Extended-spectrum β-lactamase-producing Escherichia coli isolated from poultry: a review of current problems, illustrated with some laboratory findings Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat Evaluation of the antibiotic resistance and virulence of Escherichia coli strains isolated from chicken carcasses in Prevalence and risk factors for carriage of antimicrobial-resistant Escherichia coli on household and small-scale chicken farms in the Mekong Delta of Vietnam Detection of extended-spectrum beta-lactamase-producing Escherichia coli in market-ready chickens in Zambia Impact of unhygienic conditions during slaughtering and processing on spread of antibiotic resistant Escherichia coli from poultry The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli in poultry chickens and variation according to farming practices in Risk of transmission of antimicrobial resistant Escherichia coli from commercial broiler and free-range retail chicken in India Extraintestinal pathogenic and antimicrobial resistant Escherichia coli, Including sequence type 131 (ST131), from retail chicken breasts: United States Chicken meat as reservoir of colistin-resistant Escherichia coli carrying mcr-1 genes in South America A Survey of antimicrobial agents usage in poultry farms and antibiotic resistance in Escherichia coli and staphylococci isolates from the poultry in Ile-Ife Identification and characterization of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae isolated from healthy poultry in Brazil Characterization of cefotaxime-and ciprofloxacin-resistant commensal Escherichia coli originating from belgian farm animals indicates high antibiotic resistance transfer rates Poultry hatcheries as potential reservoirs for antimicrobial-resistant Escherichia coli: a risk to public health and food safety Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management Recombination-mediated host adaptation by avian Staphylococcus aureus Staphylococcus aureus in veterinary medicine Comparative genotypic and phenotypic characterisation of methicillin-resistant Staphylococcus aureus ST398 isolated from animals and humans Livestock-associated Staphylococcus aureus CC398: animal reservoirs and human infections Poultry: the most common food in outbreaks with known pathogens Staphylococcosis. In: Swayne DE (ed) Diseases of poultry Carriage of methicillin-resistant Staphylococcus aureus by wild urban Norway rats (Rattus norvegicus) Characterization, prevalence and antibiogram study of Staphylococcus aureus in poultry Antimicrobial resistances and virulence markers in methicillin-resistant Staphylococcus aureus from broiler and turkey: a molecular view from farm to fork Genetic characterisation of antimicrobial resistance and virulence genes in Staphylococcus aureus isolated from commercial broiler chickens in the Durban metropolitan area, South Africa Extended-spectrum β-lactamases and/or carbapenemases-producing Enterobacteriaceae isolated from retail chicken meat in Zagazig Characterization of Staphylococcus aureus from raw meat samples in Tunisia: detection of clonal lineage ST398 from the African Continent Molecular characterization and antimicrobial resistance profile of methicillin-resistant Staphylococcus aureus in retail chicken Prevalence of panton valentine leukocidin (pvl) gene in methicillin resistant Staphylococcus aureus isolated from market samples of chicken meat Characteristics of the antimicrobial resistance of Staphylococcus aureus isolated from chicken meat produced by different integrated broiler operations in Korea Antimicrobial resistance: its emergence and transmission Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci When phage, plasmids, and transposons collide: genomic islands, and conjugative-and mobilizable-transposons as a mosaic continuum Mechanisms and spread of bacterial resistance to antimicrobial agents Resistance plasmid families in Enterobacteriaceae Plasmids and the spread of resistance Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides Disinfectant resistance mechanisms, crossresistance, and co-resistance Phenotypic and genotypic characterization of Salmonella enterica in captive wildlife and exotic animal species in Colonization of specific regions of the reproductive tract and deposition at different locations inside eggs laid by hens infected with Salmonella Enteritidis or Salmonella Heidelberg Strategies to control Salmonella in the broiler production chain Prebiotics: the concept revisited Competitive exclusion in poultry--30 years of research Application of prebiotics and probiotics in poultry production Ability of bacteriophages isolated from different sources to reduce Salmonella enterica serovar Enteritidis in vitro and in vivo The posthatch prophylactic use of ceftiofur affects the cecal microbiota similarly to the dietary sanguinarine supplementation in broilers Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro Impact of a Macleaya cordata-derived alkaloid extract on necrotic enteritis in broilers Pharmacokinetics of sanguinarine, chelerythrine, and their metabolites in broiler chickens following oral and intravenous administration Strategies to modulate the intestinal microbiota and their effects on nutrient utilization, performance, and health of poultry The effect of flavophospholipol (Flavomycin) and salinomycin sodium (Sacox) on the excretion of Clostridium perfringens, Salmonella Enteritidis, and Campylobacter jejuni in broilers after experimental infection Microbiological risk assessment in feedingstuffs for food-producing animals -Scientific Opinion of the Panel on EFSA Panel on Contaminants in the Food Chain (CONTAM) (2010) Scientific opinion on lead in food Scientific Opinion on the development of a risk ranking framework on biological hazards & EMA Committee for Medicinal Products for Veterinary Use (CVMP) (2017) ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and foodproducing animals Food and Drug Administration Food and Drug Administration Food and Drug Administration (2000) Enrofloxacin for poultry; opportunity for hearing, notice National Antimicrobial Resistance Monitoring System: two decades of advancing public health through integrated surveillance of antimicrobial resistance Available at: www. fda. gov/ downl oads/ Anima lVete rinary/ Safet yHeal th/ Antim icrob ialRe sista nce/ Natio nalAn timic robia lResi stanc eMoni torin gSyst em/ UCM23 6283 National Action Plan for the Prevention and Control of Antimicrobial Resistance (PAN-BR) National Action Plan for the Prevention and Control of Antimicrobial Resistance in Livestock (2018b) Available in Portuguese at Antimicrobial use, resistance and economic benefits and costs to livestock producers in Brazil. OECD Food, Agriculture and Fisheries Papers Judicious therapeutic use of antimicrobials Use of antimicrobial agents and occurrence of antimicrobial resistancein bacteria from food animals, food and humans in Denmark Use of antimicrobial agents and occurrence of antimicrobial resistancein bacteria from food animals, food and humans in Denmark The European ban on growth-promoting antibiotics and emerging consequences for human and animal health Antibiotic use in animals-prejudices, perceptions and realities Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties One Health: over a decade of progress on the road to sustainability Executive summary of the AVMA one health initiative task force report Veterinary medicine and human health WHO -World Health Organisation (2015) Global action plan on antimicrobial resistance WHO -World Health Organisation (2017) WHO guidelines on use of medically important antimicrobials in food-producing animals FAO -Food and Agriculture Organization of the Uined Nations The FAO action plan on antimicrobial resistance Rome Available online at Critical importance of a one health approach to antimicrobial resistance The authors wish to express their thanks for the financial support of Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, financial code 001), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), and Sao Paulo Research Foundation (FAPESP, proc. 2018/21301-2 and 2020/06076-2). Funding for fellowship to conduct studies in Eastern Africa was provided by the NIH Fogarty International Center to WG and SK, Grant no. D43 TW008650. The authors declare no competing interests.